CRISPR THERAPEUTICS AG Increase (Decrease) in Deferred Revenue
CRISPR THERAPEUTICS AG (CRSP) reported Increase (Decrease) in Deferred Revenue of -$244.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-07
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$26.00K, a 102.82% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$218.00K, a 132.78% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$22.76M, a 3365.57% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $457.00K, a 10.39% decline year-over-year.
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for fiscal 2017 was -$20.72M, a 1180.75% decline from fiscal 2016.
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for fiscal 2016 was $1.92M, a 97.45% decline from fiscal 2015.
- CRISPR THERAPEUTICS AG increase (decrease) in deferred revenue for fiscal 2015 was $75.09M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$244.00K 10-Q · filed 2018-08-07 | -$23.00M derived: sum of 3 quarters · filed 2018-08-07 | -$22.55M derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | -$218.00K 10-Q · filed 2018-05-08 | -$22.98M derived: sum of 2 quarters · filed 2018-05-08 | -$22.52M derived: sum of 3 quarters · filed 2018-05-08 | -$21.60M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-12-31 | -$22.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$22.30M derived: sum of 2 quarters · filed 2018-03-08 | -$21.38M derived: sum of 3 quarters · filed 2018-08-07 | -$20.72M 10-K · filed 2018-03-08 |
| 2017-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.38M derived: sum of 2 quarters · filed 2018-08-07 | $2.04M 10-Q · filed 2017-11-08 | $2.74M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-06-30 | $921.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.59M 10-Q · filed 2018-08-07 | $2.28M derived: sum of 3 quarters · filed 2018-08-07 | $2.79M derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | $665.00K 10-Q · filed 2018-05-08 | $1.36M derived: sum of 2 quarters · filed 2018-05-08 | $1.87M derived: sum of 3 quarters · filed 2018-05-08 | $2.43M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.21M derived: sum of 2 quarters · filed 2018-03-08 | $1.77M derived: sum of 3 quarters · filed 2018-03-08 | $1.92M 10-K · filed 2018-03-08 |
| 2016-09-30 | $510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.07M derived: sum of 2 quarters · filed 2017-11-08 | $1.22M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $559.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $710.00K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $151.00K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $75.09M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |